Mattel Soars as Barbie Strength, Cost Cuts Fuel Wall Street Beat
(Bloomberg) -- Mattel Inc. continued to shake off the liquidation of major customer Toys “R” Us Inc. and used aggressive cost cutting to blow past Wall Street estimates during the crucial holiday quarter. The shares rose sharply after the close of trading in New York.
- Adjusted earnings of 4 cents a share were a welcome surprise for analysts who'd expected a loss of 14 cents.
Key Insights
- Chief Executive Officer Ynon Kreiz set out a two-pronged strategy to turn around the ailing toymaker when he took the reins in April: first cut costs and boost profitability, then revive sales growth by creating more entertainment around properties such as Barbie and Hot Wheels. Step one is paying off, and step two is in the works.
- Key to the profit beat was a big expansion in gross profit margin to 46.6 percent, a marked improvement from 30.7 percent a year ago. The company accelerated a cost-cutting program aimed at administrative expenses, which it slashed by double digits this quarter.
- Barbie is once again a billion-dollar brand with $1.09 billion in annual revenue. That marks the first time it's hit that threshold since 2014.
- The impact of Toys “R” Us isn't totally gone, with revenue posting a sixth-straight quarterly drop. But the drag should dissipate in the second half of 2019, Kreiz said in an interview on Thursday. “We aren't claiming victory,” he said. “We have a long way to go, but we are tracking well.”
- Investors interested in the state of the toy industry will get more color on Friday when rival Hasbro Inc. reports.
Market Reaction
- Shares rose as much as 19 percent on Thursday in after-hours trading.
- Through Thursday, the stock had fallen 27 percent in the past year, compared to a 0.9 percent gain for the S&P 500.
- Read more here.
To contact the reporter on this story: Matt Townsend in New York at mtownsend9@bloomberg.net
To contact the editor responsible for this story: Anne Riley Moffat at ariley17@bloomberg.net
©2019 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.